Tune into our Podcast Series

The provided texts describe Breath Diagnostics Inc. and its OneBreath™ technology, a novel lung cancer detection method using breath analysis. OneBreath™ employs a microreactor to capture and quantify volatile organic compounds (VOCs) indicative of lung cancer, offering a non-invasive, cost-effective, and highly sensitive alternative to current screening methods like low-dose CT scans. The documents detail the technology's measurement process, study designs, performance metrics, competitive advantages, and the company's team and financial standing. Several sources highlight the significant unmet need for improved lung cancer screening due to low compliance rates and limitations of existing methods. Finally, some materials discuss the potential for OneBreath™ to detect other diseases beyond lung cancer.